COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,188 Articles (22,198 medRxiv, 7,990 bioRxiv)

Most recent first Previous |  Page 1255: Articles 12541-12550  | Next

Immunogenic SARS-CoV2 Epitopes Defined by Mass Spectrometry
Pan, K., Chiu, Y., Huang, E., Chen, M., Wang, J., Lai, I., Singh, S., Shaw, R., MacCoss, M. J., Yee, C.
10.1101/2021.07.20.453160 — Posted: 2021-07-21
Viral receptor profiles of masked palm civet revealed by single-cell transcriptomics
Chen, D., Ou, Z., Wang, H., Zhang, Y., Zhu, J., An, F., Xu, J., Ding, X., Ding, P., Luo, L., Wu, W., Qin, Q., Wei, Y., Zhao, W., Lv, Z., Lan, T., Li, M., Zhang, W., Liu, H., Hua, Y.
10.1101/2021.07.20.452903 — Posted: 2021-07-21
Medication Use Patterns in COVID-19 Positive Patients in a large state-wide health system by Age Group, Comorbidity, and Month During the Pandemic in 2020
Watanabe, J. H., Kwon, J., Nan, B., Abeles, S. R., Mehta, S.
10.1101/2021.07.15.21259539 — Posted: 2021-07-21
Previously unrecognized non-reproducible antibody-antigen interactions and their implications for diagnosis of viral infections including COVID-19
Pan, J., Yang, L., Deng, Y., Sun, B., Zhang, L., Wu, W., Li, J., Cheng, H., Li, Y., Xu, W., Yang, J., Sun, Y., Fei, H., Xue, Q., Zhou, Y., Wang, H., Zheng, P., Chen, H., Zhu, F. C., Peng, D., Gu, D., Han, J., Qiu, J., Ma, H.
10.1101/2021.07.20.453011 — Posted: 2021-07-20
HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses
Buckley, P., Lee, C. H.-j., Pinho, M. P., Babu, R. O., Woo, J., Antanaviciute, A., Simmons, A., Ogg, G., Koohy, H.
10.1101/2021.07.17.452778 — Posted: 2021-07-20
Evaluating discharges and readmissions using a COVID Virtual Ward model: a retrospective data study assessing patient outcomes and the likely staffing commitment
Gallier, S., Atkin, C., Reddy-Kolanu, V., Parekh, D., Zou, X., Evison, f., Ball, S., Sapey, E.
10.1101/2021.07.16.21260651 — Posted: 2021-07-20
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021
Bhuiyan, T. R., Dent Hulse, J., Hegde, S., Akhtar, M., Islam, T., Hasan Khan, Z., Khan, I. I., Rashid, M., Rashid, R., Shirin, T., Gurley, E. S., Khan, A. I., Azman, A. S., Qadri, F.
10.1101/2021.07.16.21260611 — Posted: 2021-07-20
Forecasting admissions in psychiatric hospitals before and during Covid-19
Wolff, J., Klimke, A., Marschollek, M., Kacprowski, T.
10.1101/2021.07.16.21260200 — Posted: 2021-07-20
Modeling shield immunity to reduce COVID-19 transmission in long-term care facilities
Lucia-Sanz, A., Magalie, A., Rodriguez-Gonzalez, R., Leung, C.-Y., Weitz, J. S.
10.1101/2021.07.16.21260657 — Posted: 2021-07-20
Modelling infectious disease transmission potential as a function of human behaviour
Walters, C. E., Bekker-Nielsen Dunbar, M., Weston, D., Hall, I. M.
10.1101/2021.07.16.21260521 — Posted: 2021-07-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).